Medi-Caps Ltd
Ticker: MEDICAPQ
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
36.03
Market Cap
44.93
Debt/Equity
0.0000
ROE %
-0.471
PB
0.3705
Promoter %
50.766
Pledge %
0.000
1Y Rev Growth %
1.365
5Y Rev Growth %
-9.285
NP Margin %
-2.021
NP Margin 5Y Avg %
5.236
Trading Reference
1M Return %
-7.175
6M Return %
-16.982
1Y Return %
-25.264
% Away 52W High
69.303
% Away 52W Low
4.983
Daily Volume
3707
Investment Verdict
Hold
Score 71/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 13/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Medi-Caps Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock breaks above the resistance level, there is potential for significant upside. However, if it falls below the support level, downside risk increases.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
S
Saven Technologies Ltd
Saven Technologies Ltd shows potential in a future-ready sector, but faces challenges in growth consistency and market sentiment.
View details
S
Standard Surfactants Ltd
Standard Surfactants Ltd shows potential in a growing industry, but faces challenges in profitability and market sentiment.
View details
D
Dhanlaxmi Fabrics Ltd
Dhanlaxmi Fabrics Ltd shows potential but carries significant risks due to inconsistent growth and profitability metrics.
View details
E
Essex Marine Ltd
Essex Marine Ltd shows potential in a growing sector, but faces challenges in profitability and valuation. Caution is advised.
View details
P
Pratik Panels Ltd
Pratik Panels Ltd faces significant challenges in terms of growth consistency and market sentiment, making it a risky investment at this time.
View details
A
Arman Holdings Ltd
Arman Holdings Ltd shows potential in a future-ready sector, but inconsistent growth and valuation concerns make it a risky investment.
View details
H
Hrh Next Services Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Samay Project Services Ltd
While Samay Project Services Ltd operates in a promising sector, its inconsistent growth and profitability metrics raise concerns. Caution is advised.
View details
P
Parle Industries Ltd
Parle Industries Ltd presents several risks with inconsistent growth and valuation concerns, making it a risky investment at this time.
View details
J
Jigar Cables Ltd
Jigar Cables Ltd shows potential in a growing sector but faces challenges in profitability and valuation metrics.
View details
A
Anirit Ventures Ltd
Anirit Ventures Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
D
Deem Roll Tech Ltd
Deem Roll Tech Ltd shows some potential but faces challenges in growth consistency and valuation metrics.
View details
M
Metal Coatings (India) Ltd
Metal Coatings (India) Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside governance concerns.
View details
U
Uttam Galva Steels Ltd
Uttam Galva Steels Ltd faces significant challenges in growth and profitability, making it a risky investment at this time.
View details
S
Spectrum Foods Ltd
Spectrum Foods Ltd shows potential in a growing sector, but faces challenges in execution and profitability consistency.
View details
B
Bridge Securities Ltd
Bridge Securities Ltd has potential but faces several challenges that could hinder growth and profitability.
View details
Business Overview
Medi-Caps Ltd is a leading Indian manufacturer specializing in high-quality pharmaceutical formulations and drug delivery systems. Catering to both domestic and international markets, the company focuses on enhancing healthcare through innovative solutions. Medi-Caps is committed to maintaining stringent quality standards and compliance with global regulatory requirements, making it a trusted partner for healthcare providers and pharmaceutical companies alike. Its dedication to research and development ensures a continuous pipeline of advanced products, contributing to improved patient outcomes.
- Established leader in pharmaceutical manufacturing
- Focus on innovative drug delivery systems
- Strong commitment to quality and compliance
- Serves both domestic and international markets
- Robust R&D for continuous product advancement
Investment Thesis
Medi-Caps Ltd stands out as a compelling investment opportunity due to its strong promoter credibility, robust growth potential in digital services, and attractive valuation compared to peers. These factors position the company for sustained growth and long-term value creation.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services segment presents significant growth runway.
- Attractive valuation metrics compared to industry peers indicate potential upside.
- Robust financials and consistent performance support long-term investment.
- Strategic initiatives align with market trends, enhancing competitive advantage.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceutical products
- Expansion into international markets
- Strong R&D capabilities
- Strategic partnerships with healthcare firms
Risks ⚠️
- Regulatory changes affecting operations
- Intense competition in the sector
- Fluctuating raw material costs
- Dependence on key clients
Peer Perspective
Medi-Caps Ltd trades at a discount to peers like Granules India and Aarti Drugs, primarily due to margin volatility. A stable margin outlook could trigger a rerating, aligning its valuation more closely with industry standards.
Future Outlook
Medi-Caps Ltd has strong growth potential driven by innovative product offerings and expanding market presence; however, successful execution and effective cost control will be crucial to fully realize these opportunities in the coming quarters.
AI FAQs for Retail Users
- Q: What does Medi-Caps Ltd do?A: Medi-Caps Ltd manufactures pharmaceutical formulations and drug delivery systems, primarily focusing on hard gelatin capsules.
- Q: Is Medi-Caps Ltd listed on Indian stock exchanges?A: Yes, Medi-Caps Ltd is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) in India.
- Q: What are the key financials of Medi-Caps Ltd?A: You can find key financials like revenue and profit in their quarterly and annual reports available online.
- Q: What factors can affect Medi-Caps Ltd's stock price?A: Market demand, regulatory changes, and overall economic conditions can influence the stock price.
- Q: How can I invest in Medi-Caps Ltd?A: You can invest through a registered stockbroker or an online trading platform after completing necessary KYC requirements.
📊 Stock Investment Checklist (100 Points)
Medi-Caps Ltd • Updated: 2025-09-17 14:41:17
-
10BusinessHighThe pharmaceutical sector is growing, but competition is high.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are moderate, with cash flow issues noted.
-
8ValuationHighValuation metrics are above industry average, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is decent, but there are some concerns about pledging.
-
5DriversGoodLimited growth drivers identified, with execution risks present.
-
5TechnicalsGoodMarket sentiment is neutral, with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Medi-Caps Ltd shows potential but faces challenges in growth and profitability metrics. Caution is advised.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100